The Effect of Combination of Red and White Bahman Retrieved of Iranian Traditional Medicine on Semen Parameters in Idiopathic Oligospermic Men

Sponsor
Royan Institute (Other)
Overall Status
Unknown status
CT.gov ID
NCT02998593
Collaborator
(none)
200
1
2
11
18.2

Study Details

Study Description

Brief Summary

This study is a prospective double blind randomized controlled trial to investigate the effect of red and white bahman on semen parameters, sexual hormones and DNA defragmentation in idiopathic oligospermic men .Include patients will take the medicine and placebo in different two case and control groups for 3 month and semen parameters and other variants at the start and end of study.

Condition or Disease Intervention/Treatment Phase
  • Drug: Bahman capsules
  • Drug: Placebo
Phase 3

Detailed Description

This is a randomized, double blind; placebo-controlled clinical trial has been started from july 2016 and will continue to july 2016 in Royan institute. The eligible patients who fulfilled the study criteria will be included in the trial.

Study protocol and assays All the patients will have a complete history evaluation and physical examination by the attending urologist who is blinded to the study and enter the study according to inclusion criteria.. semen analysis and hormonal laboratory tests [Testosterone, Luteinizing hormone (LH) Follicle stimulating hormone(FSH)] will done in same lab at start of study and 3 month after. Intervention time is 3 month for each patient. semen analysis wil be done according to who laboratory manual for the examination and processing of human semen 5th edition and hormonal tests (LH,FSH,Testosterone) with Elisa method (with score of International Unit). DNA Defragmentation will evaluate with Sperm Chromatin Structure Assay(SCSA) method. semen parameters which will evaluate is the number of normal and abnormal shape sperms, velocity of sperms, volume and viscosity of semen at start and end of the study. medicine and placebo prescribe in 500mg capsules for 3month. red and white Bahman is an effective medicine in male infertility treatment In Iranian Traditional Medicine. at the end of study main aim of the study is evaluation effect of combination of Red and White Bahman retrieved of Iranian Traditional Medicine on Semen Parameters in Idiopathic Oligospermic . Red Bahman and White bahman ,nutrition ,placebo, smoking and Testosterone,LH,FSH,Concentration,number,sha-pe,of sperm before and after the study is variables of study.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Effect of Red and White Bahman on Semen Parameters,Testosteron ,LH, FSH and Defragmentation of DNA . A Double Blind Randomised Clinical Trial (Phase 3)
Study Start Date :
Jul 1, 2016
Anticipated Primary Completion Date :
Apr 1, 2017
Anticipated Study Completion Date :
Jun 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: extracted red Bahman and white bahman

500 mg of extracted red Bahman and white bahman that is used once a day.

Drug: Bahman capsules
Oral Use of Bahman capsules for 3 months by patients.

Placebo Comparator: Placebo

500 mg of placebo once time a day

Drug: Placebo
Oral use of placebo capsules by patients for 3 months.

Outcome Measures

Primary Outcome Measures

  1. Semen analysis [3 months]

    Performing the semen analysis to evaluate the sperm count ,sperm motility and sperm morphology.

Secondary Outcome Measures

  1. Testosterone [3 months]

    Evaluation the testosterone by ELISA level 3 months after intervention.

  2. FSH [3 months]

    Evaluation the FSH level by ELISA 3 months after intervention.

  3. LH [3 months]

    Evaluation the LH level by ELISA 3 months after intervention.

  4. DNA defragmentation [3 months]

    Evaluation the DNA defragmentation by SCSA Method 3 months after intervention.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 45 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. all idiopathic oligospermic patient in range of 20 to 45 years old

  2. sperm count under 15 million /ml 3;No history of taking chemical or herbal medicine effective on sperm genesis in last 3 month( like Hormonal drug ,antidepressant ,anti hypertension,cimetidine, cyproteron, sulphasalazine, flutamide, spironolactone, estrogen,opium 4:No history of Varicocele and Obstructive disease 5:;No leukocytospermia

Exclusion Criteria:

Taking chemical or herbal medicine effective on spermatogenesis (hormonal and sperm reducing and increasing agent); 2. ; Increasing BMI > 30 3. Leukocytospermia 4. varicocele

Contacts and Locations

Locations

Site City State Country Postal Code
1 Royan Institute Tehran Iran, Islamic Republic of

Sponsors and Collaborators

  • Royan Institute

Investigators

  • Study Chair: Hamid Gourabi, PhD, Head of Royan Institute
  • Study Director: Seyed Jalil Hosseini, PhD, Department of Andrology, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
  • Study Director: Mahmoudreza Faghihi, MD,PhD, Shahid Beheshti University of Medical Science _School of Traditional Medicine,Tehran ,Iran
  • Principal Investigator: Mina Movahed, MD,PhD, Shahid Beheshti University of Medical Science _School of Traditional Medicine,Tehran ,Iran

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Royan Institute
ClinicalTrials.gov Identifier:
NCT02998593
Other Study ID Numbers:
  • Royan-Emb-026
First Posted:
Dec 20, 2016
Last Update Posted:
Apr 28, 2017
Last Verified:
Oct 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Royan Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 28, 2017